| Emilee L. O'brien Licsw Llc | |
|
1320 G St Geneva NE 68361-2104 | |
| (402) 768-8491 | |
| Not Available |
| Full Name | Emilee L. O'brien Licsw Llc |
|---|---|
| Speciality | Social Worker |
| Location | 1320 G St, Geneva, Nebraska |
| Authorized Official Name and Position | Emilee Lauren O'brien (SOLE PROPRIETOR) |
| Authorized Official Contact | 4027688491 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Emilee L. O'brien Licsw Llc 1705 G. Street Geneva NE 68361 Ph: (402) 768-8491 | Emilee L. O'brien Licsw Llc 1320 G St Geneva NE 68361-2104 Ph: (402) 768-8491 |
| NPI Number | 1184195760 |
|---|---|
| Provider Enumeration Date | 12/07/2018 |
| Last Update Date | 12/07/2018 |
| Medicare PECOS PAC ID | 6305180043 |
|---|---|
| Medicare Enrollment ID | O20181206000587 |
News Archive
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arresting growth of cultured cancer cells. But apart from a very rare type of lymphoma, these drugs unfortunately do not clinically affect malignant tumors," says Prof. Dr. Olaf Witt, who heads a research department at DKFZ and is pediatrician at the Center for Child and Adolescent Medicine of Heidelberg University Hospital.
Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184195760 | NPI | - | NPPES |
| 1932625647 | Other | NE | BCBS |
| 1932625647 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Emilee L O'brien |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932625647 PECOS PAC ID: 8820363484 Enrollment ID: I20171006001411 |
News Archive
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arresting growth of cultured cancer cells. But apart from a very rare type of lymphoma, these drugs unfortunately do not clinically affect malignant tumors," says Prof. Dr. Olaf Witt, who heads a research department at DKFZ and is pediatrician at the Center for Child and Adolescent Medicine of Heidelberg University Hospital.
Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.
› Verified 3 days ago
News Archive
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arresting growth of cultured cancer cells. But apart from a very rare type of lymphoma, these drugs unfortunately do not clinically affect malignant tumors," says Prof. Dr. Olaf Witt, who heads a research department at DKFZ and is pediatrician at the Center for Child and Adolescent Medicine of Heidelberg University Hospital.
Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.
› Verified 3 days ago
Fillmore County Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1900 F Street, Geneva, NE 68361 Phone: 402-759-3192 Fax: 402-759-3186 | |
Lemke-michels Psychotherapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 942 N 13th St, Geneva, NE 68361 Phone: 402-759-3802 Fax: 402-759-3803 | |
Michael S. Becker, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 942 N 13th St, Geneva, NE 68361 Phone: 402-759-3802 Fax: 402-759-3803 | |
Tera L Stokebrand, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 942 N 13th St, Geneva, NE 68361 Phone: 402-230-9130 Fax: 402-759-3803 | |
Red Couch Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 914 P Street, Geneva, NE 68361 Phone: 402-710-0564 | |
Fillmore County Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1900 F St, Geneva, NE 68361 Phone: 402-759-3167 Fax: 402-759-3505 |